Trial Profile
EFFICACY AND SAFETY OF ZOFENOPRIL + HYDROCHLOROTHIAZIDE COMBINATION VS IRBESARTAN + HYDROCHLOROTHIAZIDE COMBINATION IN ESSENTIAL HYPERTENSIVE PATIENTS NOT CONTROLLED BY PREVIOUS MONOTHERAPY.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Zofenopril (Primary) ; Hydrochlorothiazide; Irbesartan
- Indications Essential hypertension
- Focus Therapeutic Use
- 17 Jun 2013 Results presented at the 23rd European Meeting on Hypertension.
- 02 Aug 2011 New trial record